REGN
Valuation Healthcare · Biotechnology Data as of 2026-06-30P/E Ratio · Metrics
P/E Ratio
12.84
PEG Ratio
0.16
Dividend Yield
-
Gross Margin
86.56%
Net Margin
30.23%
Revenue CAGR 3Y
10.76%
ROE
16.36%
ROA
12.43%
Buyback Yield
0.84%
Current Ratio
3.34
Magic Earn Yield
8.59%
Altman Z-Score
5.84
Fair Value River
Score
Valuation 75
Profitability 57
Growth 36
Health 100
Yield 14